Effects of Whey Protein and Collagen Supplementation

January 28, 2020 updated by: Andreo Fernando Aguiar, Universidade Norte do Paraná

Effects of Whey Protein and Collagen Supplementation on Muscle Mass and Function During Training in Young Adults

The present project aims to investigate the effects of high-quality protein (whey protein) vs. low-quality protein (collagen) on muscle mass and function (e.g., strength and power) during a 10-wk resistance training program in young adults. It will be tested the hypothesis that leucine-matched collagen should promote similar gains on muscle function and mass compared to whey protein supplementation.

Study Overview

Detailed Description

The purpose of this study will be to investigate the effects of whey protein vs. leucine-matched collagen supplementation on muscle mass and function after a 10-wk resistance training program. Initially, all participants will be submitted for a 2-wk familiarization period, and then randomized into two groups (N = 11 / group): whey protein group and leucine-matched collagen group. The following variables will be assessed from pre-to post-training: anthropometric, muscle thickness from vastus lateralis and biceps brachii muscles using ultrasound, training load, mean power and peak torque for unilateral arm flexion exercise using a isokinetic dynamometer, countermovement vertical jump, nutritional intake, and testosterone-to-cortisol ratio . Shapiro-Wilk and Levine tests will be used to test the normality and homogeneity of the measurements, respectively. Two-way ANOVA (group x time) tests for repeated measures will be performed to assess changes over time and between groups for all dependent variables. Violation of sphericity will adjust using Greenhouse- Geyser correction. The Bonferroni post-hoc test will detect specific differences between groups. When appropriate, the percentage of change (∆%) will be reported according to the following equation: ∆% = [(pre-average post average) / pre-average mean] × 100. Values will be express as mean ± standard deviation. O significance level α will be 0.05.

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Paraná
      • Londrina, Paraná, Brazil, 86.041-140
        • Universidade Norte do Paraná

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Men and women aged 18-35 years
  • To be eutrophic (not overweight or obese)

Exclusion Criteria:

  • To present a history of musculoskeletal disorders
  • Be attending a systematized weight training program for at least six months
  • To make use of medicines that could affect muscle function.
  • To have used ergogenic supplements and anabolic steroids for at least six months before study
  • To have restrictions for exercises practice considering Physical Activity Readiness Questionnaire (PAR-Q) responses.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Whey Protein
Each participant will be supplemented with whey protein (7 d/wk) during 10 weeks.
35 g of whey protein (7 d/wk) during a 10-wk resistance training program (3 d/wk; 3 sets of 8-12 repetitions with an interval of 1-2 minutes between sets and exercises) involving the leg press, leg extension, and arm flexion exercises. The load will be adjusted weekly.
EXPERIMENTAL: Leucine-matched collagen
Each participant will be supplemented with collagen (7 d/wk) during 10 weeks.
35 g of collagen (7 d/wk) + 2 g of leucine during a 10-wk resistance training program (3 d/wk; 3 sets of 8-12 repetitions with an interval of 1-2 minutes between sets and exercises) involving the leg press, leg extension, and arm flexion exercises. The load will be adjusted weekly.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in biceps brachii thickness
Time Frame: Baseline and after 10 weeks
Measured by ultrasonography pre- and post-training
Baseline and after 10 weeks
Change in muscle strength by training load
Time Frame: Baseline, 5 and 10 weeks
Training load for leg press, knee extension, and arm flexion exercises
Baseline, 5 and 10 weeks
Change in vertical jump
Time Frame: Baseline and after 10 weeks
Countermovement vertical jump performance will be assessed using the Smart Jump instrument
Baseline and after 10 weeks
Change in mean power
Time Frame: Baseline and after 10 weeks
Mean power using a isokinetic dynamometer (BIODEX)
Baseline and after 10 weeks
Change in peak torque
Time Frame: Baseline and after 10 weeks
Peak torque using a isokinetic dynamometer (BIODEX)
Baseline and after 10 weeks
Change in vastus lateralis thickness
Time Frame: Baseline and after 10 weeks
Measured by ultrasonography pre- and post-training
Baseline and after 10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in testosterone-to-cortisol ratio
Time Frame: Baseline and after 10 weeks
Blood samples will be collected for analyse of the testosterone-to-cortisol ratio
Baseline and after 10 weeks
Dietary intake
Time Frame: Baseline, 2, 5, 10 weeks
Dietary intake to be assessed using 3-day diet recalls.
Baseline, 2, 5, 10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andreo Aguiar, Universidade Norte do Paraná

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 1, 2019

Primary Completion (ACTUAL)

November 1, 2019

Study Completion (ACTUAL)

December 5, 2019

Study Registration Dates

First Submitted

December 11, 2019

First Submitted That Met QC Criteria

December 27, 2019

First Posted (ACTUAL)

December 30, 2019

Study Record Updates

Last Update Posted (ACTUAL)

January 30, 2020

Last Update Submitted That Met QC Criteria

January 28, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertrophy

Clinical Trials on Whey protein supplementation

3
Subscribe